Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Amifostine (Ethyol) as a Protectant in Metastatic Ovarian and Non-Small Cell Lung Cancer in Paclitaxel/Carboplatin-Treated Patients: A Comparative Trial

NCT00003072 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT00003072
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00003072 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Amifostine (Ethyol) as a Protectant in Metastatic Ovarian and Non-Small Cell Lung Cancer in Paclitaxel/Carboplatin-Treated Patients: A Comparative Trial
Lead sponsor
University of California, San Francisco
Phase
Phase 2
Overall status
Completed
Start date
May 31, 1997
Completion date
October 31, 1998
Enrollment
80 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer, neurotoxicity, ovarian cancer